HYFT
ImmunoPrecise Antibodies Ltd.
1.50$
+11.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.0% | 48.6% | 51.9% | 59.2% | 48.9% | 46.4% | 36.1% | 51.7% | 35.5% | 40.7% | 39.4% | 41.4% | 39.2% | |
| 48.0% | 51.4% | 48.1% | 40.8% | 51.1% | 53.6% | 63.9% | 48.3% | 64.5% | 59.3% | 60.6% | 58.6% | 60.8% | |
| 13.6% | 16.1% | 14.4% | 60.2% | 37.6% | 17.2% | 15.6% | 33.2% | 29.7% | 29.2% | 38.2% | 33.5% | 32.6% | |
| 53.8% | 67.2% | 63.8% | 135.6% | 106.5% | 58.4% | 53.1% | 104.2% | 74.5% | 120.4% | 128.8% | 182.1% | 125.7% | |
| 82.3% | 105.1% | 102.6% | 232.3% | 202.4% | 107.1% | 84.8% | 179.7% | 131.5% | 147.6% | 165.8% | 218.4% | 165.2% | |
| -34.3% | -53.7% | -54.4% | -191.5% | -151.3% | -53.5% | -20.9% | -131.4% | -67.0% | -88.4% | -105.2% | -159.9% | -104.4% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | – | 0.0% | 0.0% | 0.0% | – | – | |
| -42.1% | -55.6% | -291.4% | -197.3% | -159.7% | -398.9% | -27.2% | -132.2% | -77.4% | -94.9% | -102.8% | -154.6% | -106.8% | |
| -3.0% | -12.5% | -12.0% | -26.9% | -27.3% | -49.0% | 3.7% | -2.9% | 0.6% | -0.4% | -8.9% | 4.1% | -1.2% | |
| -39.2% | -43.1% | -279.4% | -161.7% | -95.3% | -349.9% | -31.0% | -93.6% | -77.5% | -94.5% | -93.9% | -158.7% | -105.5% | |
| -12.3% | -34.4% | -266.9% | -140.7% | -102.4% | -373.4% | -14.2% | -102.4% | -72.4% | -89.7% | -99.4% | -152.9% | -103.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.